Annual Total Debt
$572.00 K
-$5.28 M-90.22%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total debt is $572.00 thousand, with the most recent change of -$5.28 million (-90.22%) on December 31, 2023.
- During the last 3 years, CTNM annual total debt has fallen by -$4.34 million (-88.35%).
- CTNM annual total debt is now -90.22% below its all-time high of $5.85 million, reached on December 31, 2022.
Performance
CTNM Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$611.00 K
+$14.00 K+2.35%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total debt is $611.00 thousand, with the most recent change of +$14.00 thousand (+2.35%) on September 30, 2024.
- Over the past year, CTNM quarterly total debt has increased by +$39.00 thousand (+6.82%).
- CTNM quarterly total debt is now -89.55% below its all-time high of $5.85 million, reached on December 1, 2022.
Performance
CTNM Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
CTNM Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.2% | +6.8% |
| 3 y3 years | -88.3% | -89.5% |
| 5 y5 years | -88.3% | -89.5% |
CTNM Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.2% | at low | -89.5% | -100.0% |
| 5 y | 5-year | -90.2% | at low | -89.5% | -100.0% |
| alltime | all time | -90.2% | at low | -89.5% | -100.0% |
Contineum Therapeutics Class A Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $611.00 K(+2.3%) |
| Jun 2024 | - | $597.00 K(+2.1%) |
| Mar 2024 | - | $585.00 K(+2.3%) |
| Dec 2023 | $572.00 K | $572.00 K(-49.0%) |
| Sep 2023 | - | $1.12 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $5.85 M(+19.1%) | - |
| Dec 2022 | - | $5.85 M |
| Dec 2021 | $4.91 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total debt?
- What is the all time high annual total debt for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual total debt year-on-year change?
- What is Contineum Therapeutics Class A quarterly total debt?
- What is the all time high quarterly total debt for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly total debt year-on-year change?
What is Contineum Therapeutics Class A annual total debt?
The current annual total debt of CTNM is $572.00 K
What is the all time high annual total debt for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total debt is $5.85 M
What is Contineum Therapeutics Class A annual total debt year-on-year change?
Over the past year, CTNM annual total debt has changed by -$5.28 M (-90.22%)
What is Contineum Therapeutics Class A quarterly total debt?
The current quarterly total debt of CTNM is $611.00 K
What is the all time high quarterly total debt for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total debt is $5.85 M
What is Contineum Therapeutics Class A quarterly total debt year-on-year change?
Over the past year, CTNM quarterly total debt has changed by +$39.00 K (+6.82%)